{
  "id": 20315921,
  "title": "IISc researchers combine antibiotics to tackle drug-resistant TB",
  "url": "https://urgent.news/2026/11/16/iisc-researchers-combine-antibiotics-to-tackle-drug-resistant-tb",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-16T19:19:08.000Z",
  "source": {
    "name": "The Hindu",
    "slug": "the-hindu",
    "url": "https://www.thehindu.com/news/national/karnataka/iisc-researchers-combine-antibiotics-to-tackle-drug-resistant-tb/article71708093.ece"
  },
  "original_language": "en",
  "account": "Researchers at the Indian Institute of Science (IISc) have developed a strategy to restore the effectiveness of isoniazid, a crucial drug used to treat tuberculosis (TB). Isoniazid, which is considered highly effective against the bacterium Mycobacterium tuberculosis, is increasingly showing resistance among TB-causing bacteria. This resistance poses a significant challenge in treating TB, a persistent health issue globally. The IISc researchers found that combining isoniazid with vancomycin can reverse resistance and reduce bacterial load in a mouse model. Professor Nagasuma Chandra from the Department of Biochemistry, who led the study, explained that this combination has shown promising results in clinical isolates of M. tuberculosis, including those resistant to isoniazid and multidrug-resistant (MDR) strains. The study, published in Microbiology Spectrum, suggests that this drug combination could be a potential treatment strategy to overcome isoniazid resistance. Further research is underway to advance this combination for clinical trials.",
  "summary": null,
  "key_points": [
    "IISc researchers develop strategy to restore isoniazid effectiveness against TB.",
    "Combining isoniazid with vancomycin reverses resistance in mouse model.",
    "Study published in Microbiology Spectrum suggests potential TB treatment."
  ],
  "editors_take": "Combining isoniazid with vancomycin offers a new pathway to bypass bacterial resistance, potentially restoring the utility of a critical antibiotic against multidrug-resistant tuberculosis strains.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}